You Create the Future of
Regenerative Medicine.
There Smoother.
Transitioning cell and gene therapies from lab to patient is intricate, involving many requirements and standards like GMP. CCRM Nordic is a not for profit organization supported by the Swedish Government offering the expertise and facilities needed to navigate these challenges.
Development Expertise
We engage in many parts of building a business, from CMC, analytical and process development to business support helping companies with critical aspects such as de-risking, technology and therapy development and IP.
GMP Facilities and Clinical Manufacturing
We are building approximately 3000 sqm lab facilities covering analytical and process development and GMP manufacturing for clinical studies.
Industry Network & Global Reach
As a CCRM hub we are part of a global network. We work with the industry in a long-term manner to support ATMP development from all angles, including lowering COGS and improving regulatory standards.
“Advancing cell and gene therapies requires collaborations that make technologies and solutions accessible to early-stage researchers. Creating an infrastructure that provides access to scalable and flexible solutions will enable research to progress at greater speed. Cytiva is proud to work with CCRM to help accelerate the development of next generation therapeutics.”
Catarina Flyborg
Senior Advisor, CCRM Board Director
What is CCRM Nordic?
CCRM Nordic is a not for profit organization with the purpose to address bottlenecks in the translation and commercialization of advanced therapy medicinal products (ATMPs). We are based in Gothenburg Sweden, supporting innovators in the Nordics and Europe.
Backed and Trusted by Both Private and Public Sector
CCRM Nordic is a public-private partnership, backed by well renowned industry leaders, SMEs and the Swedish Innovation Agency Vinnova.